Gout
📧 Sign up to get email alerts when something new happens for Gout.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-01-05Clinical Trial Update: Arthritis Research UK Gout Treatment Trial - Phase 2 [NA]
A Phase 2 gout treatment clinical trial conducted by Arthritis Research UK has completed; no results are provided in the update.
-
CLINICAL_TRIALS trial_result · 2016-11-11Clinical Trial Update: Efficacy, Safety And Tolerability Of PF-06743649 In Gout Subjects. [Phase 1]
Phase 1 study of PF-06743649 in gout patients was terminated; results evaluating efficacy, safety, and tolerability were posted in 2016.
-
CLINICAL_TRIALS trial_result · 2016-11-03Clinical Trial Update: Efficacy and Safety of Extended Release and Immediate Release Febuxostat in Participants With Gout and Moderate Renal Impairment [Phase 2]
A Phase 2 trial evaluating the efficacy and safety of extended-release and immediate-release febuxostat in patients with gout and moderate r…
-
CLINICAL_TRIALS trial_result · 2016-11-03Clinical Trial Update: Efficacy and Safety of Extended Release and Immediate Release Febuxostat in Participants With Gout [Phase 3]
Phase 3 trial comparing extended-release and immediate-release febuxostat in gout patients evaluated efficacy and safety outcomes.
-
CLINICAL_TRIALS trial_result · 2016-10-21Clinical Trial Update: Safety and Pharmacodynamics of SEL-037 (Pegsiticase) in Subjects With Elevated Blood Uric Acid Levels [Phase 1]
Phase 1 study evaluating the safety and pharmacodynamics of SEL-037 (Pegsiticase) in patients with gout and elevated uric acid; the trial ha…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-10-05Clinical Trial Update: Bucillamine for the Treatment of Acute Gout Flare in Subjects With Moderate to Severe Gout [Phase 2]
Phase 2 clinical trial evaluating Bucillamine for acute gout flares in patients with moderate to severe gout has completed.
-
CLINICAL_TRIALS trial_result · 2016-09-13Clinical Trial Update: Optimal Administration of Allopurinol in Dialysis Patients [Phase 4]
Phase 4 clinical trial evaluating the optimal administration of allopurinol in dialysis patients has completed.
-
CLINICAL_TRIALS trial_result · 2016-09-02Clinical Trial Update: RDEA3170 PK/PD Study [Phase 1]
Phase 1 PK/PD study of RDEA3170 for gout has completed.
-
CLINICAL_TRIALS trial_result · 2016-08-30Clinical Trial Update: Purine Metabolism Enzyme SNP to Uric Acid Production
A clinical trial evaluating the link between a purine metabolism enzyme SNP and uric acid production in gout and hyperuricemia has completed…
-
CLINICAL_TRIALS trial_result · 2016-08-18Clinical Trial Update: Combining Lesinurad With Allopurinol in Inadequate Responders [Phase 3]
A Phase 3 trial evaluated adding lesinurad to allopurinol in gout patients who did not respond adequately, with results posted in 2016.
-
CLINICAL_TRIALS trial_result · 2016-06-20Clinical Trial Update: Efficacy and Safety of HuZhen Capsule for Treatment of Patients With Acute Gout [Phase 3]
Phase 3 trial assessing the efficacy and safety of HuZhen Capsule for acute gout; no results are provided in this update.
-
CLINICAL_TRIALS trial_result · 2016-05-30Clinical Trial Update: Postmarketing Study to Determine Performance of the SIGMA HP® PARTIAL KNEE SYSTEM [Phase 4]
Phase 4 postmarketing study to evaluate the performance of the SIGMA HP Partial Knee System. The study status is COMPLETED.
-
CLINICAL_TRIALS trial_result · 2016-05-26Clinical Trial Update: Combination Treatment Study in Subjects With Tophaceous Gout With Lesinurad and Febuxostat [Phase 3]
A Phase 3 clinical trial evaluating the combination of lesinurad and febuxostat for tophaceous gout has completed and posted results.
-
CLINICAL_TRIALS trial_result · 2016-05-26Clinical Trial Update: Combining Lesinurad With Allopurinol in Inadequate Responders [Phase 3]
Phase 3 trial evaluating adding lesinurad to allopurinol in gout patients inadequately responding to allopurinol; results were posted in 201…
-
CLINICAL_TRIALS trial_result · 2016-05-26Clinical Trial Update: Open-Label Lesinurad Monotherapy Extension Study in Gout [Phase 3]
An open-label extension study of lesinurad monotherapy for gout has completed Phase 3 research, with results posted in 2016.
-
CLINICAL_TRIALS trial_result · 2016-04-27Clinical Trial Update: Food Effect Study of Febuxostat XR in Healthy Participants [Phase 1]
Phase 1 food-effect study of Febuxostat XR in healthy participants with results posted.
-
CLINICAL_TRIALS trial_result · 2016-03-31Clinical Trial Update: Extended Drug Utilization Study Among Patients Exposed to Ticagrelor, Clopidogrel and Prasugrel
This clinical trial update reports the completion of an extended drug utilization study evaluating adverse events among patients exposed to …
-
CLINICAL_TRIALS trial_result · 2016-02-12Clinical Trial Update: Lesinurad Monotherapy in Gout Subjects Intolerant to Xanthine Oxidase Inhibitors [Phase 3]
Result update from a Phase 3 trial of lesinurad monotherapy in gout patients intolerant to xanthine oxidase inhibitors; the study has comple…
-
CLINICAL_TRIALS trial_result · 2016-02-03Clinical Trial Update: Safety and Efficacy of Oral Febuxostat in Subjects With Gout [Phase 3]
This is a Phase 3 trial assessing safety and efficacy of oral febuxostat in gout, with results posted.
-
CLINICAL_TRIALS trial_result · 2015-09-04Clinical Trial Update: Effects of Fasting on Self Efficacy
A completed clinical trial (NCT02113111) sponsored by Universität Duisburg-Essen evaluated the effects of fasting on self-efficacy across co…
-
CLINICAL_TRIALS trial_result · 2015-07-01Clinical Trial Update: RDEA3170 Monotherapy in Subjects With Gout [Phase 2]
This update reports the completion of a Phase 2 monotherapy trial of RDEA3170 in subjects with gout.
-
CLINICAL_TRIALS trial_result · 2015-06-12Clinical Trial Update: A PD/Safety Study of RDEA3170 in Combination With Febuxostat for Treating Gout or Asymptomatic Hyperuricemia Patients [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating the combination of RDEA3170 with febuxostat for gout and asymptomatic hyperuricemia has completed.
-
CLINICAL_TRIALS trial_result · 2015-04-17Clinical Trial Update: Safety and Efficacy Study of MBX-102 in Treatment of Hyperuricemia in Patients With Gout [Phase 2]
Phase 2 trial update reporting safety and efficacy findings for MBX-102 in treating hyperuricemia in patients with gout.
-
CLINICAL_TRIALS trial_result · 2015-04-17Clinical Trial Update: Evaluate the PK, PD, and Safety of Arhalofenate in Combination With Febuxostat for Hyperuricemia in Patients With Gout [Phase 2]
Phase 2 trial update reporting pharmacokinetics, pharmacodynamics, and safety of combining arhalofenate with febuxostat in patients with gou…
-
CLINICAL_TRIALS trial_result · 2015-04-03Clinical Trial Update: Open Label Safety/Efficacy Study of Arhalofenate in Combination With Febuxostat for Hyperuricemia in Gout Patients [Phase 2]
Open-label Phase 2 safety and efficacy study of combining arhalofenate with febuxostat for hyperuricemia and gout has completed.